Bayer CropScienceBOM:506285 +0.29%87 Current Ratio is 1.92 as of Mar. 2026, which is 17% below its 10-year median of 2.30. GuruFocus rates BOM:506285 with a GF Score™ of 87/100 and a GF Value™ of ₹5,902.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 259 Agriculture companies, Bayer CropScience ranks better than 59.85% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Bayer CropScience's current ratio for the quarter that ended in Mar. 2026 was 1.92.
Bayer CropScience has a current ratio of 1.92. It generally indicates good short-term financial strength.
The historical rank and industry rank for Bayer CropScience's Current Ratio or its related term are showing as below:
BOM:506285'
s Current Ratio Range Over the Past 10 Years
Min: 1.92 Med: 2.3 Max: 3.48
Current: 1.92
During the past 13 years, Bayer CropScience's highest Current Ratio was 3.48. The lowest was 1.92. And the median was 2.30.
BOM:506285's Current Ratio is ranked better than 59.85% of 259
companies
in the Agriculture industry
Industry Median: 1.58
vs BOM:506285: 1.92
Bayer CropScience (BOM:506285) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Bayer CropScience Current Ratio Related Terms
Bayer CropScience Current Ratio Historical Data
* Premium members only.
The historical data trend for Bayer CropScience's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:506285 vs CTVA, CF, MOS: Current Ratio Comparison
For the Agricultural Inputs subindustry, Bayer CropScience's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayer CropScience Current Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bayer CropScience's Current Ratio distribution charts can be found below:
* The bar in red indicates where Bayer CropScience's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayer CropScience (BOM:506285) has a Current Ratio of 1.92 as of Mar. 2026. This is 17% below median its historical median of 2.30. Over the past decade, Bayer CropScience's Current Ratio has ranged from 1.92 to 3.48. According to the industry distribution chart, Bayer CropScience ranks #104 out of 259 companies in the Agriculture industry, placing it in the top 40.2%.
Is Bayer CropScience's Current Ratio too high?
Bayer CropScience's current Current Ratio of 1.92 is 17% below median its 10-year median of 2.30. Over the past 10 years, this metric has ranged from a low of 1.92 to a high of 3.48. The Agriculture industry median Current Ratio is 1.58. Bayer CropScience's value of 1.92 is 21.5% above this industry median. Based on the distribution chart, Bayer CropScience ranks #104 out of 259 companies in the Agriculture industry, which is above the industry midpoint. Overall, Bayer CropScience has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's Current Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Bayer CropScience ranks #104 out of 259 companies for Current Ratio. This puts Bayer CropScience in the upper half of its industry. The industry median Current Ratio is 1.58. Bayer CropScience's value of 1.92 is 21.5% above this benchmark. Historically, Bayer CropScience's own Current Ratio has ranged from 1.92 to 3.48 over the past decade. While the company's 10-year median is 2.30 vs. the industry median of 1.58, Bayer CropScience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for an Agriculture company?
The median Current Ratio among Agriculture companies is 1.58, based on 259 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayer CropScience's current Current Ratio of 1.92 is 21.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median Current Ratio is 1.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayer CropScience's current Current Ratio is 1.92, which is 17% below median its own 10-year median of 2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹5,902.44, compared to a current price of ₹4,131.75 — trading 30% below its estimated fair value. The current Current Ratio is 1.92, which is 17% below median its 10-year median of 2.30 and 21.5% above the Agriculture industry median of 1.58. Bayer CropScience's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current Current Ratio is 1.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer CropScience (BOM:506285) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued.
The current stock price of ₹4,131.75 is trading 30% below its estimated GF Value™ of ₹5,902.44.
GuruFocus considers Bayer CropScience to be Significantly Undervalued.
Key valuation signals for BOM:506285:
Current Ratio: 1.92 (17% below median its 10-year median of 2.30)
GF Value™: ₹5,902.44 vs. price of ₹4,131.75 (30% below fair value)
Industry Position: 21.5% above the Agriculture median (#104 of 259)
No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
87GF Score
Get the complete analysis for BOM:506285
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506285 has been successfully added to your 
